FindTrial
Sign In

Autologous transplantation of cord blood derived stem cells for neonatal hypoxic - ischemic encephalopatly

Autologous transplantation of cord blood derived stem cells for neonatal hypoxic - ischemic encephalopatly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000922
Enrollment
Unknown
Registered
2010-06-27
Start date
2008-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hypoxic - ischemic encephalopatly

Interventions

A:conventional treatment+autologous transplantation of cord blood
B:conventional treatment

Sponsors

Guagndong Maternal and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. less than 24 hours after birth; 2. PH of cord blood during birth < 7.0; 3. Apgar's score <7; 4. showing HIE presentation; 5. having written consent from the parents.

Exclusion criteria

Exclusion criteria: 1. maternal sepsis; 2. chromosome abnormality or contagious disease; 3. severe congenital anomaly; 4. failure of cord blood collection or transplantation

Design outcomes

Primary

MeasureTime frame
electroencephalogram;intellectual development;behavior development;neuron specific enolase(NSE);diffusion-weighted imaging(DWI);—

Secondary

MeasureTime frame
clinical presentations;blood routine, urine routine, liver function and kidney function;—

Countries

China

Contacts

Public ContactXiao-zhuang Zhang
zxz3861@163.com+86 020 61118648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026